BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 33952592)

  • 21. Multiple Biomarker Testing Tissue Consumption and Completion Rates With Single-gene Tests and Investigational Use of Oncomine Dx Target Test for Advanced Non-Small-cell Lung Cancer: A Single-center Analysis.
    Yu TM; Morrison C; Gold EJ; Tradonsky A; Layton AJ
    Clin Lung Cancer; 2019 Jan; 20(1):20-29.e8. PubMed ID: 30243889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular analysis of endobronchial ultrasound needle aspirates in patients with non-small cell lung cancer: Results from the SCOPE database.
    Vakil E; Dumoulin E; Stollery D; Gillson AM; MacEachern P; Dhaliwal I; Mitchell M; Li P; Schieman C; Romatowski N; Chee AC; Tyan CC; Fortin M; Hergott CA; Tremblay A
    Cytopathology; 2024 May; 35(3):378-382. PubMed ID: 38349229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accuracy of endoscopic ultrasound-guided needle aspiration specimens for molecular diagnosis of non-small-cell lung carcinoma.
    Su W; Tian XD; Liu P; Zhou DJ; Cao FL
    World J Clin Cases; 2020 Nov; 8(21):5139-5148. PubMed ID: 33269250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adequacy of Samples Obtained by Endobronchial Ultrasound with Transbronchial Needle Aspiration for Molecular Analysis in Patients with Non-Small Cell Lung Cancer. Systematic Review and Meta-Analysis.
    Labarca G; Folch E; Jantz M; Mehta HJ; Majid A; Fernandez-Bussy S
    Ann Am Thorac Soc; 2018 Oct; 15(10):1205-1216. PubMed ID: 30011388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EBUS-FNA cytologic-histologic correlation of PD-L1 immunohistochemistry in non-small cell lung cancer.
    Jug R; Giovacchini CX; Liu B; Green CL; Clarke JM; Mahmood K; Pavlisko EN
    J Am Soc Cytopathol; 2020; 9(6):485-493. PubMed ID: 32336671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Programmed death-ligand 1 testing of lung cancer cytology specimens obtained with bronchoscopy.
    Stoy SP; Rosen L; Mueller J; Murgu S
    Cancer Cytopathol; 2018 Feb; 126(2):122-128. PubMed ID: 29053224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Programmed Death Ligand 1 Testing of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Samples Acquired For the Diagnosis and Staging of Non-Small Cell Lung Cancer.
    Smith A; Wang H; Zerbo A; Beaudoin S; Ofiara L; Fiset PO; Benedetti A; Gonzalez AV
    J Bronchology Interv Pulmonol; 2020 Jan; 27(1):50-57. PubMed ID: 31513030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Testing for Targeted Therapy in Advanced Non-Small Cell Lung Cancer: Suitability of Endobronchial Ultrasound Transbronchial Needle Aspiration.
    Casadio C; Guarize J; Donghi S; Di Tonno C; Fumagalli C; Vacirca D; Dell'Orto P; De Marinis F; Spaggiari L; Viale G; Barberis M
    Am J Clin Pathol; 2015 Oct; 144(4):629-34. PubMed ID: 26386084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Cytology Specimens for Next Generation Sequencing in Non-small-cell Lung Cancer.
    Stoy SP; Segal JP; Mueller J; Furtado LV; Vokes EE; Patel JD; Murgu S
    Clin Lung Cancer; 2018 May; 19(3):230-238.e2. PubMed ID: 29277564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating the Genomic Yield of a Single Endobronchial Ultrasound-guided Transbronchial Needle Aspiration in Lung Cancer: Meeting the Challenge of Doing More With Less.
    Leong TL; Christie M; Kranz S; Pham K; Hsu A; Irving LB; Asselin-Labat ML; Steinfort DP
    Clin Lung Cancer; 2017 Nov; 18(6):e467-e472. PubMed ID: 28576592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ALK translocation detection in non-small cell lung cancer cytological samples obtained by TBNA or EBUS-TBNA.
    Bravaccini S; Tumedei MM; Ulivi P; Zoli W; Calistri D; Candoli P; Amadori D; Puccetti M
    Cytopathology; 2016 Apr; 27(2):103-7. PubMed ID: 25757141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knowledge and Practice Patterns Among Pulmonologists for Molecular Biomarker Testing in Advanced Non-small Cell Lung Cancer.
    Fox AH; Jett JR; Roy UB; Johnson BE; King JC; Martin N; Osarogiagbon RU; Rivera MP; Rosenthal LS; Smith RA; Silvestri GA
    Chest; 2021 Dec; 160(6):2293-2303. PubMed ID: 34181954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suitability of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration versus Paired Transbronchial Biopsy Specimens for Evaluating Programmed Death Ligand-1 Expression in Stage III and IV Lung Cancer: A Comparative Retrospective Study.
    Matsuoka H; Araya T; Kita T; Terada N; Yamamura K; Nishikawa S; Tambo Y; Sone T; Kimura H; Ooi A; Kasashima S; Kawashima A; Kasahara K
    J Cancer; 2021; 12(15):4478-4487. PubMed ID: 34149911
    [No Abstract]   [Full Text] [Related]  

  • 34. Heterogeneity analysis of PD-L1 expression and copy number status in EBUS-TBNA biopsy specimens of non-small cell lung cancer: Comparative assessment of primary and metastatic sites.
    Yoshimura K; Inoue Y; Karayama M; Tsuchiya K; Mori K; Suzuki Y; Iwashita Y; Kahyo T; Kawase A; Tanahashi M; Ogawa H; Yokomura K; Inui N; Funai K; Shinmura K; Niwa H; Suda T; Sugimura H
    Lung Cancer; 2019 Aug; 134():202-209. PubMed ID: 31319982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular testing in lung cancer: fine-needle aspiration specimen adequacy and test prioritization prior to the CAP/IASLC/AMP Molecular Testing Guideline publication.
    Rafael OC; Aziz M; Raftopoulos H; Vele OE; Xu W; Sugrue C
    Cancer Cytopathol; 2014 Jun; 122(6):454-8. PubMed ID: 24723383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between Classic Driver Oncogene Mutations in EGFR, ALK, or ROS1 and 22C3-PD-L1 ≥50% Expression in Lung Adenocarcinoma.
    Rangachari D; VanderLaan PA; Shea M; Le X; Huberman MS; Kobayashi SS; Costa DB
    J Thorac Oncol; 2017 May; 12(5):878-883. PubMed ID: 28104537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EBUS-TBNA provides highest RNA yield for multiple biomarker testing from routinely obtained small biopsies in non-small cell lung cancer patients - a comparative study of three different minimal invasive sampling methods.
    Schmid-Bindert G; Wang Y; Jiang H; Sun H; Henzler T; Wang H; Pilz LR; Ren S; Zhou C
    PLoS One; 2013; 8(10):e77948. PubMed ID: 24205040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Re-biopsy by endobronchial ultrasound procedures for mutation analysis of non-small cell lung cancer after EGFR tyrosine kinase inhibitor treatment.
    Izumo T; Matsumoto Y; Chavez C; Tsuchida T
    BMC Pulm Med; 2016 Jul; 16(1):106. PubMed ID: 27457475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Endobronchial Ultrasound Guided Transbronchial Needle Aspiration for The Diagnosis and Genotyping of Lung Cancer].
    Chen M; Shao C; Xu Y; Sun X; Zhao J; Chen Y; Zhao Y; Zhong W; Wang M
    Zhongguo Fei Ai Za Zhi; 2018 Sep; 21(9):670-676. PubMed ID: 30201065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Success of genomic profiling of non-small cell lung cancer biopsies obtained by trans-thoracic percutaneous needle biopsy.
    Gill RR; Murphy DJ; Kravets S; Sholl LM; Janne PA; Johnson BE
    J Surg Oncol; 2018 Dec; 118(7):1170-1177. PubMed ID: 30261097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.